MOH starts Ivermectin trial for high risk COVID-19 patients - Health D-G
The MOH and the Institute for Clinical Research (ICR) have started clinical trials to study the use and efficacy of Ivermectin for high-risk COVID-19 patients at 12 MOH hospitals.
Sat Jun 05 2021